Antibiotic Resistance, Mechanisms of Evasion, and Future Medical Strategies

Biological Costs of Resistance and Selection Pressure

• The Energetic Cost of Protection: Microbes must balance resource allocation. Producing mechanisms for protection (resistance) requires "making more things," which necessitates more food intake.
      * In environments where protection is not needed, being "over-protected" is disadvantageous because the organism may die from lack of resources.
      * In a stable population where no threat is present, resistant microbes are likely to be selected against because of this high metabolic cost, keeping their numbers low.

• Evolutionary Selection via Antibiotics: The application of antibiotics acts as a selective pressure on a microbial population.
      * Applying the drug kills off the non-resistant microbes.
      * The surviving population consists almost entirely of resistant microbes.
      * As these survivors repopulate, the new generation is mostly resistant because the "parents" were resistant. This transition represents the primary problem in antibiotic overuse.

Clinical Guidelines and Common Misconceptions

• Avoidance of Unnecessary Use: Antibiotics should not be used unless strictly necessary.
      * Inappropriate Prescribing: Common examples include prescribing antibiotics for pediatric colds or ear infections.
      * Viral vs. Bacterial: Many such infections are viral, and as the speaker notes, "these drugs aren't even gonna help" against viruses.

• The Necessity of Extreme Dosing: If antibiotics are taken, they must be administered at a dose and duration sufficient to destroy even the resistant microbes.
      * Time-Concentration Basis: Resistance is often time-concentration based. Repeatedly "hitting" microbes with an antibiotic can eventually kill them, as they simply die less quickly than non-resistant ones.

• The Dangers of Incomplete Courses: Patients often stop taking medication after five days because they "feel better."
      * Feeling better occurs because most microbes have been knocked out, but not all.
      * Survivors of an incomplete course return "strong" and can repopulate the host with more resistant strains.
      * All-or-None Perspective: There is no "middle ground" or "mild" use of antibiotics. The speaker describes it as an extreme: either no antibiotics at all, or hitting the infection "really hard."

• Broad Spectrum vs. Narrow Spectrum: Broad-spectrum antibiotics affect the whole microbiome, not just the pathogen.
      * This can lead to the development of highly resistant microbes in the gut, such as $C. diff$ ($Clostridioides\,difficile$).

Mechanisms of Acquired Microbial Resistance

• The speaker identifies five primary ways microbes physically acquire resistance, focusing on slides 53 and 54.

• 1. Drug Inactivation: Microbes produce enzymes that physically break down the drug.
      * Example: Penicillinase (also known as Beta-lactamase).
      * Action: The enzyme destroys the active beta-lactam ring of the antibiotic, rendering it ineffective.

• 2. Decreased Permeability: Microbes change or mutate their receptors to prevent drug entry.
      * Drugs typically enter cells via specific receptors (illustrated as a "bone-shaped" receptor).
      * By mutating the receptor's shape, the microbe causes a loss of specificity, ensuring the drug physically cannot get inside the cell.

• 3. Drug Pumps (Efflux Pumps): The microbe creates a specialized pump that identifies the drug.
      * Even if the drug manages to enter the cell, the pump immediately transports it back out before it can take effect.

• 4. Change in Drug Binding Site: The microbe mutates the internal structure that the drug targets.
      * Context: Protein synthesis inhibitors like tetracycline, aminoglycosides, or macrolids target the ribosome.
      * Mechanism: The ribosome mutates its binding site (e.g., changing from a "triangle-shaped" site to a "circle-shaped" site) so the drug no longer fits and cannot prevent protein synthesis.

• 5. Use of Alternate Metabolic Pathways: When a drug blocks a specific metabolic step (e.g., preventing step C from becoming step D), the microbe bypasses the block.
      * The microbe performs the same function via a different pathway that the drug cannot affect, essentially using a "decoy" or "behind the scenes" route.

Future Directions and Alternative Antimicrobial Strategies

• Projected Mortality: Antibiotic resistance is a major global threat, potentially leading to $10\text{ million}$ deaths per year by $2050$.

• Current Crisis: In the United States, patients are already dying in hospitals because they harbor infections resistant to every available antibiotic.

• The Antibiotic Race: Microbes mutate faster than humans can develop new drugs. The speaker suggests, "We are going to lose the antibiotic race."

• Alternative Solutions:
      * Phage Therapy: Using bacteriophages (viruses that infect bacteria).
          * Advantages: They are specific to bacteria (cannot hurt humans), they kill via lysis (they don't "bud"), and they mutate faster than bacteria, allowing them to "win" the mutation race.
      * Disarming Bacteria: Instead of killing pathogens (which triggers natural selection), scientist can block their virulence.
          * If the bacteria are rendered harmless but allowed to live, there is no selective pressure to develop resistance. The non-resistant ones may even flourish more.
      * AI and Machine Learning: Using technology to develop antibiotics more quickly and creating rapid diagnostics.
      * Rapid Diagnostics: Finding ways to identify pathogens in minutes or hours without culturing them would allow for narrow-spectrum drug use instead of broad-spectrum.
      * Vaccines: Prevention reduces reliance on antibiotics entirely.
      * Microbiome Support: Using fecal transplants, probiotics, or prebiotics to manage infections without inducing resistance.

Questions & Discussion

• Question on Duration: A student asks how long one should take antibiotics and when to stop, mentioning a mother-in-law in India who buys antibiotics over-the-counter and takes them for months for leg edema.
      * Response: The duration is prescriber-based. Acute infections are typically $10\text{--}14$ days, while chronic infections require long-term treatment. However, the speaker strongly advises against self-medicating with over-the-counter antibiotics as seen in India.

• Question on Resistance in Humans: A student asks if humans can become resistant to painkillers like they do with antibiotics.
      * Response: This is different. Humans do not become "resistant" in the microbial sense; they increase "tolerance."
      * Example (Alcohol): To maintain homeostasis, the body starts making more alcohol-breakdown enzymes if consumed repeatedly, causing the drug to be broken down immediately.
      * Pain Meds: The body adjusts to the presence of the drug, requiring higher doses for the same effect, which is distinct from microbial genetic resistance.

• Concluding Anecdote: The speaker references the game "Oregon Trail" where characters frequently die of simple diseases like dysentery. The sticker on the speaker's laptop says, "Get in, loser. We're going shopping," juxtaposed with Oregon Trail imagery, highlighting that without functioning antibiotics, we risk returning to an era where "silly diseases" are fatal.